metricas
covid
Annals of Hepatology Most often read
Journal Information

Most often read

966272
Skin manifestations of liver diseases
A. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
966272
Open access
134440
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
134440
Open access
Open Article
98302
Effects of systemic chemotherapy on the liver
Giuliano Ramadori, Silke Cameron
Ann Hepatol. 2010;9:133-43
98302
Open access
84506
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
84506
Full text access
74151
Bile Acid Physiology
Agostino Di Ciaula, Gabriella Garruti, Raquel Lunardi Baccetto, Emilio Molina-Molina, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa
Ann Hepatol. 2017;16 Supl 1:S4-S14
74151
Open access
63638
Diagnosis of liver nodules within and outside screening programs
Massimo Colombo
Ann Hepatol. 2015;14:304-9
63638
Open access
59660
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status
Marcelo Eidi Nita, Nelson Gaburo, Hugo Cheinquer, Gilbert L’ltalien, Evaldo Stanislau Affonso de Araujo, Patricia Mantilla, Nancy Cure-Bolt, Paulo A. Lotufo
Ann Hepatol. 2009;8:339-45
59660
Open access
47124
Current concepts in alcohol metabolism
Juan Caballería
Ann Hepatol. 2003;2:60-8
47124
Open access
45467
Treatment of hyperferritinemia
Melanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
45467
Open access
43710
Transmission routes of hepatitis C virus infection
Eduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
43710
Open access
43227
Shark liver oil: hidden dangers
Serta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
43227
Open access
41049
Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children
Judith Flores-Calderón, Segundo Morán-Villota, Solange-Heller Rouassant, Jesús Nares-Cisneros, Flora Zárate-Mondragón, Beatriz González-Ortiz, José Antonio Chávez-Barrera, Rodrigo Vázquez-Frías, ... Gustavo Varela-Fascinetto
Ann Hepatol. 2013;12 Supl 1:S3-S24
41049
Open access
40566
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
40566
Open access
39856
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
39856
Open access
38755
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
Helen H. Wang, Gabriella Garruti, Min Liu, Piero Portincasa, David Q.-H. Wang
Ann Hepatol. 2017;16 Supl 1:S27-42
38755
Open access
38114
Beta blockers in portal hypertension. Are they really a good option?
Eric López-Méndez, Misael Uribe
Ann Hepatol. 2006;5:86-91
38114
Open access
36597
Hepatic Hydrothorax
Yong Lv, Guohong Han, Daiming Fan
Ann Hepatol. 2018;17:33-46
36597
Open access
35636
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
35636
Open access
34720
Silymarin is an ally against insulin resistance: A review
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:100255
34720
Open access
34302
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds
Renata Koníčková, Kateřina Vaňková, Jana Vaníková, Katerina Vánová, Lucie Muchová, Iva Subhanová, Marie Zadinová, Jaroslav Zelenka, ... Libor Vítek
Ann Hepatol. 2014;13:273-83
34302
Open access